Los Angeles, California 90024

  • Substance Dependence


The purpose of this study is to determine whether substance abuse treatment designed specifically for drug-dependent women offenders provides better outcomes than standard drug court treatment (mixed-gender programs).

Study summary:

In this five-year study, a total of 300 women entering court-referred treatment throughout Los Angeles County and who agree to participate in the study will be randomly assigned to a women-focused or to a mixed-gender outpatient treatment program. The study will assess the impact of women-focused substance abuse treatment using outcome measures including recidivism, substance abuse and relapse, and social adjustment (e.g., employment, parenting behaviors, psychological improvement, and HIV risk reduction behaviors), compared to the impact of traditional mixed-gender programs. Assessments will occur at baseline and at 1 month, 12 months, and 24 months after admission.


Inclusion Criteria: - Drug court participant - At least eighteen (18) years old - Have had no more than three prior non-violent, non-drug felony convictions - Do not have a current charge of driving under the influence of alcohol or drugs or a charge of sale or transportation of drugs Exclusion Criteria: - Not capable of giving informed consent



Primary Contact:

Principal Investigator
Michael Prendergast, Ph.D.
University of California, Los Angeles

Elizabeth Hall, Ph.D.
Phone: (310)445-0874 ext. 332
Email: ehall@ucla.edu

Backup Contact:


Location Contact:

Los Angeles, California 90024
United States

Elizabeth Hall, Ph.D.
Phone: 310-312-0500
Email: ehall@ucla.edu

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: September 27, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.